Literature DB >> 34033221

Atypical presentations of erythema nodosum leprosum: Diagnostic and therapeutic aspects.

Rania Alakad1,2, Ahmad Nofal1,2, Magda Assaf3,2.   

Abstract

Classic erythema nodosum leprosum (ENL) is characterized clinically by abrupt eruption of tender erythematous nodules, papules and plaques. Variable atypical patterns have been described, for example pustular, bullous, ulcerative, necrotic and Sweet's syndrome-like ENL. We aim to review previously reported cases of atypical ENL addressing the diagnostic and therapeutic aspects of these uncommon presentations. A search of medical literature for all cases of atypical ENL was conducted in the PubMed database till 2020. Data of patients with atypical ENL were collected and analyzed to describe the epidemiological, clinico-histological and therapeutic features. The major five clinically described presentations of atypical ENL include vesiculo-bullous lesions (46 % of patients), ulcero-necrotic lesions (41 %), erythema multiforme-like lesions (28 %), Sweet's syndrome-like lesions (11 %) and pustules (9 %). The skin lesions were accompanied by fever and constitutional symptoms in all patients. Oral steroids and thalidomide were the main lines of therapy in most of the reported patients. Dermatologists and pathologists should keep in mind the clinical variability of ENL to avoid misdiagnosis and delayed management. Early recognition can help control disease progression and save the patients from further complications.
© 2021 Deutsche Dermatologische Gesellschaft (DDG). Published by John Wiley & Sons Ltd.

Entities:  

Mesh:

Year:  2021        PMID: 34033221     DOI: 10.1111/ddg.14449

Source DB:  PubMed          Journal:  J Dtsch Dermatol Ges        ISSN: 1610-0379            Impact factor:   5.584


  1 in total

1.  Next-generation sequencing-assisted diagnosis of a case of leprosy misdiagnosed as erythema multiforme.

Authors:  Yanfang Zhang; Xuezhong Lei; Jiajie Lu
Journal:  Ann Clin Microbiol Antimicrob       Date:  2022-09-07       Impact factor: 6.781

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.